scholarly journals RONC-16. RISK OF PREMATURE RADIONECROSIS IN PAEDIATRIC PATIENTS WITH HIGH RISK MEDULLOBLASTOMA TREATED WITH PROTONS ON THE CRANIUM SPINAL AXIS

2018 ◽  
Vol 20 (suppl_2) ◽  
pp. i177-i178
Author(s):  
Giovanna Stefania Colafati ◽  
Chiara Carducci ◽  
Barbara Rombi ◽  
Stefano Lorentini ◽  
Andrea Carai ◽  
...  
Keyword(s):  
High Risk ◽  
Paediatric Patients ◽  
Spinal Axis

scholarly journals 905 How to prioritise patients and safely resume elective surgery during the Covid-19 pandemic

2021 ◽  
Vol 108 (Supplement_2) ◽  
Author(s):  
H Subbiah Ponniah ◽  
M Ahmed ◽  
T Edwards ◽  
J Cobb ◽  
E Dean ◽  
...  
Keyword(s):  
Patient Safety ◽  
High Risk ◽  
Orthopaedic Surgery ◽  
Elective Surgery ◽  
Paediatric Patients ◽  
Level 3 ◽  
Level 1 ◽  
Surgical Unit

Abstract Introduction There are now over 2.5 million NHS patients awaiting elective surgery, with the most in orthopaedics. We present an algorithm and results for safely and equitably restarting surgery at COVID-light sites. Method An MDT applied the COVID-19 Algorithm for Resuming Elective Surgery (CARES) on 1169 patients awaiting elective orthopaedic surgery. It assessed safety, procedural efficacy, and biopsychosocial factors, to prioritise patients. They were assigned to five categories and underwent surgery at one of three COVID-light sites (1. access to HDU/ITU/Paediatrics/specialist equipment, 2. an NHS elective surgical unit and 3. a private elective surgical unit). Results 21 ‘Urgent’ patients received expedited care; 118 were Level 1/2; 222 were Level 3; 808 were Level 4. In 6 weeks, 355 surgeries were performed, with Urgent and Level 1/2 cases performed soonest (mean 18 days, p < 0.001). 33 high-risk/complex/paediatric patients had surgery at Site 1 and the rest at Sites 2 and 3. No patients contracted COVID-19 within 2 weeks of surgery. Conclusions We validated a widely generalisable model to facilitate resumption of elective surgery in COVID-light sites. It enabled surgery for patients in most suffering, undergoing the most efficacious procedures and/or at highest risk of deterioration, without compromising patient-safety.

scholarly journals 1113 Fever in high-risk paediatric patients presenting to european emergency departments: the perform experience

2021 ◽  
Author(s):  
Fabian van der Velden ◽  
Maria Tsolia ◽  
Enitan Carrol ◽  
Michael Levin ◽  
Werner Zenz ◽  
...  
Keyword(s):  
High Risk ◽  
Emergency Departments ◽  
Paediatric Patients

scholarly journals Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease

2015 ◽  
Vol 70 (5) ◽  
pp. 1527-1530 ◽  
Author(s):  
K. Bochennek ◽  
A. Balan ◽  
L. Müller-Scholden ◽  
M. Becker ◽  
F. Farowski ◽  
...  
Keyword(s):  
High Risk ◽  
Invasive Fungal Disease ◽  
Fungal Disease ◽  
Antifungal Prophylaxis ◽  
Paediatric Patients

Symptom Screening in Pediatrics Tool in children and adolescents with high-risk malignancies: a pilot study

2021 ◽  
pp. bmjspcare-2020-002753
Author(s):  
Sarah Szepetowski ◽  
Paul Saultier ◽  
Nicolas Andre ◽  
Vanessa Pauly ◽  
L. Lee Dupuis ◽  
...  
Keyword(s):  
High Risk ◽  
Children And Adolescents ◽  
Symptom Assessment ◽  
Self Report ◽  
Cross Sectional ◽  
High Burden ◽  
Adolescent Cancer ◽  
Symptom Screening ◽  
Paediatric Patients ◽  
Patient Reported

ObjectiveChildhood and adolescent cancer can result in high burden of distressing symptoms, particularly in high-risk malignancies. The Symptom Screening in Pediatrics Tool (SSPedi) is a reliable and valid approach to measure bothersome symptoms in paediatric patients receiving cancer treatments. Objective was to describe the feasibility of using SSPedi administration among paediatric patients with high-risk malignancies.MethodsWe conducted a single-centre, cross-sectional study of patients aged 8–18 years with high-risk malignancies in a French paediatric oncology unit. Patients self-reported the degree of bothersome symptoms using SSPedi and difficulty with SSPedi completion. The total SSPedi Score ranging from 0 to 60 (where 60 is worst) and most common moderately bothersome symptoms (scored ≥2 on 0–4 Likert Scale) were described. Feasibility was defined as more than 75% of patients agreeing to participate and more than 90% completion of SSPedi questionnaire.ResultsOut of 16 patients approached, 1 declined participation. Median age was 13 years (IQR 8–19). All were able to self-report SSPedi without difficulty. Patients experienced a median number of 6 (range 0–15) bothersome symptoms (score >0). The mean total SSPedi Score was 12 (SD=9.4). Most common moderately bothersome symptoms were pain (8/15), changes in hunger (8/15) and feeling tired (7/15).ConclusionPatient-reported symptom assessment among children and adolescents with high-risk malignancies is feasible using SSPedi. These patients experience a high burden of bothersome symptoms.

Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease

2007 ◽  
Vol 37 (3) ◽  
pp. 241-247 ◽  
Author(s):  
Nicoletta Masera ◽  
Luisa Tavecchia ◽  
Lorena Pozzi ◽  
Francesca Riva ◽  
Chiara Vimercati ◽  
...  
Keyword(s):  
High Risk ◽  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Effective Strategy ◽  
Cell Disease ◽  
Paediatric Patients
Sign in / Sign up

Export Citation Format

Share Document